Counter-Strike: Inner Circle Esports vs Sharks (BO3) - Super DraculaN Playoffs

Platform comparison

Active sub-markets

Market context

The underlying event is the Counter-Strike Semifinal 1 match between Inner Circle Esports and Sharks in the Super DraculaN Playoffs, scheduled for 8:00 AM ET on 27 June 2026 as a Best of 3 series. This contest determines which team advances, with the market resolving to Inner Circle Esports if they win, or Sharks if they prevail. A cancellation, tie, or delay beyond seven days without a winner triggers a 50-50 resolution.

Historical precedents from the lower bracket show a stark divergence between crowd sentiment and bookmaker pricing. Strafe users overwhelmingly favour Sharks Esports with 86.3% of votes, yet Thunderbird odds at the time of writing list Inner Circle as the slight favourite at 1.78 against Sharks at 1.92[2]. This mismatch mirrors cases where community polls ignore tactical nuances like map vetoes, where Inner Circle can ban Nuke to neutralise Sharks’ strongest map[2]. The current 0% prediction-market implied probability for Inner Circle appears to overreact to their lower-bracket drop, ignoring the odds divergence that suggests a more competitive contest than the crowd implies[1].

Traders must monitor the map veto outcome and any roster announcements before the series begins, as these dependencies directly influence the series trajectory. Recent coverage confirms the match format and timing, noting that map selection shapes the entire contest[2]. With the settlement window ending on 27 June 2026 at 19:40 UTC, any delay in roster confirmations or schedule changes could alter the implied probability significantly. The key catalyst is whether Inner Circle successfully executes their Nuke ban strategy to force a neutral map, a tactical move that bookmakers appear to value more highly than the prediction market currently reflects[2].

Sources: 1 · 2 · 3 · 4 · 5

Methodology

This page reviews Counter-Strike: Inner Circle Esports vs Sharks (BO3) - Super DraculaN Playoffs across five venues. We show live odds for Polymarket-based markets (sourced from the Polygon order book); for other venues we list platform attributes, since the comparable contracts are not exposed via a public API on every venue. Every CTA points at Best Prediction Markets UK — the application we operate, where you trade directly against the Polymarket order book at 0% fees.

Resolution & payout

Settlement runs on-chain. Polymarket's contract logic separates YES and NO shares as conditional tokens; at resolution the winning share lifts to $1.00 and the losing one to $0. The outcome input comes from the UMA Optimistic Oracle, which secures against bad resolution with a bond + dispute window.

Once finalised, the smart contract pays USDC to the holders' wallets within minutes — no withdrawal fees beyond Polygon network gas. Kalshi settles in USD via CFTC clearance, Betfair in account currency net of commission, Manifold in play-money mana with no cash-out.

FAQ

Where can I trade this market with the lowest fees?

On Best Prediction Markets UK, which mirrors the Polymarket order book at 0% fees. Kalshi charges up to 7% per trade; Betfair Exchange takes 2-5% commission on net winnings.

Is this market available outside the US?

Best Prediction Markets UK is available in most jurisdictions where Polymarket isn't directly accessible. Polymarket itself is geo-blocked in the US/UK/EU. Always check local regulations.

How does resolution work?

Through the UMA Optimistic Oracle on Polygon: a proposer submits the outcome, a two-hour challenge window opens, and USDC payouts settle automatically once the result is final.

What's the difference between YES and NO shares?

A YES share pays $1.00 if the event happens, $0 otherwise. A NO share pays $1.00 if the event doesn't happen. The market price between 0¢ and 100¢ is the implied probability.

How fast are USDC deposits?

Polygon credits deposits after 12 confirmations — usually under 30 seconds. Withdrawals follow the same path and land back in your wallet within minutes.